Zobrazeno 1 - 10
of 12
pro vyhledávání: '"April, Rahrig"'
Autor:
Dristhi Ragoonanan, Hisham Abdel-Azim, Aditya Sharma, Saleh Bhar, Jennifer McArthur, Renee Madden, April Rahrig, Rajinder Bajwa, Jian Wang, Victoria Sun, Mariah Wright, Rebekah Lassiter, Basirat Shoberu, Jitesh Kawedia, Sajad Jawad Khazal, Kris Michael Mahadeo
Publikováno v:
The Lancet Regional Health. Americas, Vol 33, Iss , Pp 100728- (2024)
Summary: Background: Sinusoidal obstruction syndrome is a potentially fatal complication following hematopoietic cell transplantation, high-intensity chemotherapies and increasingly seen with calicheamicin based leukemia therapies. Paediatric specifi
Externí odkaz:
https://doaj.org/article/a6460f7245804d2981330d6fd03ab969
Publikováno v:
Children, Vol 9, Iss 4, p 503 (2022)
Hyperleukocytosis in pediatric acute leukemia is associated with increased morbidity and mortality and at present there is no consensus on the use of leukapheresis (LPH) for its management. Our aim was to review characteristics and outcomes of newly
Externí odkaz:
https://doaj.org/article/9644146a1daa4b31a6a21812506c17a3
Publikováno v:
Proceedings of IMPRS. 5
This project was funded, in part, with support from the Indiana Clinical and Translational Sciences Institute funded, in part by UL1TR002529 from the National Institutes of Health. The content is solely the responsibility of the authors and does not
Autor:
Sasha Kapil, Jodi L. Skiles, April Rahrig, Carrie L. Phillips, Sushil Gupta, Carlos C Becerril Romero
Publikováno v:
Journal of Nephrology. 35:1721-1724
Autor:
Mahvish Q. Rahim, April Rahrig, Kathleen Overholt, Erin Conboy, Magdalena Czader, Amanda June Saraf
Publikováno v:
Molecular Case Studies. 9:a006256
Myelodysplastic syndrome (MDS) is a rare pediatric diagnosis characterized by ineffective hematopoiesis with potential to evolve into acute myelogenous leukemia (AML). In this report, we describe a unique case of a 17-yr-old female with an aggressive
Publikováno v:
J Adolesc Young Adult Oncol
Hypogammaglobulinemia is a poorly described complication of chemotherapy in adolescents and young adults (AYAs, 15–39 years) with acute lymphoblastic leukemia (ALL). The majority of AYAs treated on a Berlin–Frankfurt–Munster-based ALL regimen e
Publikováno v:
Critical Care Medicine. 51:345-345
Autor:
Carlos C Becerril, Romero, Sasha, Kapil, Carrie L, Phillips, April, Rahrig, Jodi L, Skiles, Sushil, Gupta
Publikováno v:
Journal of nephrology. 35(6)
495: Multiorgan Dysfunction and Critical Care Utilization Among Children With Acute Myeloid Leukemia
Publikováno v:
Critical Care Medicine. 49:239-239
Publikováno v:
Leukemia research. 71
High Risk (HR) or Very High Risk (VHR) acute lymphoblastic leukemia (ALL) treated with 4 drug induction chemotherapy is often associated with adverse events. The aim of this study was to identify risk factors associated with a prolonged inpatient len